nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—SIGMAR1—Raloxifene—osteoporosis	0.138	0.203	CbGbCtD
Fluvoxamine—CYP1A1—Cholecalciferol—osteoporosis	0.0378	0.0556	CbGbCtD
Fluvoxamine—CYP2B6—Raloxifene—osteoporosis	0.0373	0.0548	CbGbCtD
Fluvoxamine—CYP2B6—Ethinyl Estradiol—osteoporosis	0.036	0.053	CbGbCtD
Fluvoxamine—CYP1A2—Estropipate—osteoporosis	0.0328	0.0482	CbGbCtD
Fluvoxamine—CYP1A1—Estradiol—osteoporosis	0.0305	0.0448	CbGbCtD
Fluvoxamine—CYP2C9—Estropipate—osteoporosis	0.0295	0.0434	CbGbCtD
Fluvoxamine—CYP2B6—Cholecalciferol—osteoporosis	0.0288	0.0423	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0244	0.0358	CbGbCtD
Fluvoxamine—CYP3A7—Estradiol—osteoporosis	0.0244	0.0358	CbGbCtD
Fluvoxamine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0185	0.0272	CbGbCtD
Fluvoxamine—CYP2C19—Cholecalciferol—osteoporosis	0.0183	0.0269	CbGbCtD
Fluvoxamine—CYP3A5—Estradiol—osteoporosis	0.0183	0.0269	CbGbCtD
Fluvoxamine—CYP3A4—Estropipate—osteoporosis	0.0172	0.0253	CbGbCtD
Fluvoxamine—CYP3A4—Calcitriol—osteoporosis	0.0172	0.0253	CbGbCtD
Fluvoxamine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0155	0.0228	CbGbCtD
Fluvoxamine—CYP2C9—Cholecalciferol—osteoporosis	0.0152	0.0224	CbGbCtD
Fluvoxamine—CYP2C19—Estradiol—osteoporosis	0.0147	0.0217	CbGbCtD
Fluvoxamine—CYP2D6—Cholecalciferol—osteoporosis	0.0139	0.0205	CbGbCtD
Fluvoxamine—CYP3A4—Ergocalciferol—osteoporosis	0.0137	0.0202	CbGbCtD
Fluvoxamine—CYP1A2—Estradiol—osteoporosis	0.0136	0.02	CbGbCtD
Fluvoxamine—ABCB1—Conjugated Estrogens—osteoporosis	0.0136	0.0199	CbGbCtD
Fluvoxamine—CYP2C9—Estradiol—osteoporosis	0.0123	0.018	CbGbCtD
Fluvoxamine—ABCB1—Estradiol—osteoporosis	0.0119	0.0175	CbGbCtD
Fluvoxamine—CYP3A4—Raloxifene—osteoporosis	0.0115	0.0168	CbGbCtD
Fluvoxamine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0111	0.0163	CbGbCtD
Fluvoxamine—CYP3A4—Cholecalciferol—osteoporosis	0.00884	0.013	CbGbCtD
Fluvoxamine—CYP3A4—Conjugated Estrogens—osteoporosis	0.00812	0.0119	CbGbCtD
Fluvoxamine—CYP3A4—Estradiol—osteoporosis	0.00713	0.0105	CbGbCtD
Fluvoxamine—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00187	1	CbGdCrCtD
Fluvoxamine—Hypersensitivity—Ibandronate—osteoporosis	0.000111	0.000383	CcSEcCtD
Fluvoxamine—Cough—Conjugated Estrogens—osteoporosis	0.000111	0.000383	CcSEcCtD
Fluvoxamine—Dyspnoea—Risedronate—osteoporosis	0.00011	0.000382	CcSEcCtD
Fluvoxamine—Erythema multiforme—Estradiol—osteoporosis	0.00011	0.000381	CcSEcCtD
Fluvoxamine—Hypotension—Pamidronate—osteoporosis	0.00011	0.00038	CcSEcCtD
Fluvoxamine—Convulsion—Conjugated Estrogens—osteoporosis	0.00011	0.00038	CcSEcCtD
Fluvoxamine—Dry mouth—Zoledronate—osteoporosis	0.000109	0.000379	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000109	0.000379	CcSEcCtD
Fluvoxamine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000109	0.000378	CcSEcCtD
Fluvoxamine—Pruritus—Alendronate—osteoporosis	0.000109	0.000377	CcSEcCtD
Fluvoxamine—Dyspepsia—Risedronate—osteoporosis	0.000109	0.000377	CcSEcCtD
Fluvoxamine—Eye disorder—Estradiol—osteoporosis	0.000109	0.000377	CcSEcCtD
Fluvoxamine—Tinnitus—Estradiol—osteoporosis	0.000109	0.000376	CcSEcCtD
Fluvoxamine—Constipation—Ethinyl Estradiol—osteoporosis	0.000108	0.000375	CcSEcCtD
Fluvoxamine—Confusional state—Zoledronate—osteoporosis	0.000108	0.000375	CcSEcCtD
Fluvoxamine—Hypersensitivity—Calcitriol—osteoporosis	0.000108	0.000375	CcSEcCtD
Fluvoxamine—Cardiac disorder—Estradiol—osteoporosis	0.000108	0.000374	CcSEcCtD
Fluvoxamine—Chest pain—Conjugated Estrogens—osteoporosis	0.000108	0.000373	CcSEcCtD
Fluvoxamine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000108	0.000373	CcSEcCtD
Fluvoxamine—Myalgia—Conjugated Estrogens—osteoporosis	0.000108	0.000373	CcSEcCtD
Fluvoxamine—Asthenia—Ibandronate—osteoporosis	0.000108	0.000373	CcSEcCtD
Fluvoxamine—Anxiety—Conjugated Estrogens—osteoporosis	0.000107	0.000372	CcSEcCtD
Fluvoxamine—Nausea—Etidronic acid—osteoporosis	0.000107	0.000372	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Zoledronate—osteoporosis	0.000107	0.000372	CcSEcCtD
Fluvoxamine—Oedema—Zoledronate—osteoporosis	0.000107	0.000372	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000107	0.000371	CcSEcCtD
Fluvoxamine—Diarrhoea—Estropipate—osteoporosis	0.000107	0.000371	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000107	0.00037	CcSEcCtD
Fluvoxamine—Infection—Zoledronate—osteoporosis	0.000107	0.000369	CcSEcCtD
Fluvoxamine—Fatigue—Risedronate—osteoporosis	0.000107	0.000369	CcSEcCtD
Fluvoxamine—Insomnia—Pamidronate—osteoporosis	0.000106	0.000368	CcSEcCtD
Fluvoxamine—Pruritus—Ibandronate—osteoporosis	0.000106	0.000367	CcSEcCtD
Fluvoxamine—Pain—Risedronate—osteoporosis	0.000106	0.000366	CcSEcCtD
Fluvoxamine—Constipation—Risedronate—osteoporosis	0.000106	0.000366	CcSEcCtD
Fluvoxamine—Angiopathy—Estradiol—osteoporosis	0.000106	0.000366	CcSEcCtD
Fluvoxamine—Shock—Zoledronate—osteoporosis	0.000106	0.000366	CcSEcCtD
Fluvoxamine—Paraesthesia—Pamidronate—osteoporosis	0.000106	0.000365	CcSEcCtD
Fluvoxamine—Diarrhoea—Alendronate—osteoporosis	0.000105	0.000365	CcSEcCtD
Fluvoxamine—Asthenia—Calcitriol—osteoporosis	0.000105	0.000365	CcSEcCtD
Fluvoxamine—Nervous system disorder—Zoledronate—osteoporosis	0.000105	0.000364	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Zoledronate—osteoporosis	0.000105	0.000364	CcSEcCtD
Fluvoxamine—Dyspnoea—Pamidronate—osteoporosis	0.000105	0.000363	CcSEcCtD
Fluvoxamine—Tachycardia—Zoledronate—osteoporosis	0.000105	0.000363	CcSEcCtD
Fluvoxamine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000104	0.000362	CcSEcCtD
Fluvoxamine—Chills—Estradiol—osteoporosis	0.000104	0.000362	CcSEcCtD
Fluvoxamine—Somnolence—Pamidronate—osteoporosis	0.000104	0.000362	CcSEcCtD
Fluvoxamine—Pruritus—Calcitriol—osteoporosis	0.000104	0.00036	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Zoledronate—osteoporosis	0.000104	0.000359	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000104	0.000359	CcSEcCtD
Fluvoxamine—Diarrhoea—Raloxifene—osteoporosis	0.000104	0.000359	CcSEcCtD
Fluvoxamine—Dyspepsia—Pamidronate—osteoporosis	0.000103	0.000358	CcSEcCtD
Fluvoxamine—Dizziness—Estropipate—osteoporosis	0.000103	0.000358	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000103	0.000358	CcSEcCtD
Fluvoxamine—Oedema—Conjugated Estrogens—osteoporosis	0.000103	0.000358	CcSEcCtD
Fluvoxamine—Alopecia—Estradiol—osteoporosis	0.000103	0.000356	CcSEcCtD
Fluvoxamine—Infection—Conjugated Estrogens—osteoporosis	0.000103	0.000356	CcSEcCtD
Fluvoxamine—Diarrhoea—Ibandronate—osteoporosis	0.000103	0.000355	CcSEcCtD
Fluvoxamine—Anorexia—Zoledronate—osteoporosis	0.000102	0.000354	CcSEcCtD
Fluvoxamine—Decreased appetite—Pamidronate—osteoporosis	0.000102	0.000354	CcSEcCtD
Fluvoxamine—Mental disorder—Estradiol—osteoporosis	0.000102	0.000353	CcSEcCtD
Fluvoxamine—Dizziness—Alendronate—osteoporosis	0.000102	0.000353	CcSEcCtD
Fluvoxamine—Shock—Conjugated Estrogens—osteoporosis	0.000102	0.000352	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000101	0.000351	CcSEcCtD
Fluvoxamine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000101	0.000351	CcSEcCtD
Fluvoxamine—Malnutrition—Estradiol—osteoporosis	0.000101	0.000351	CcSEcCtD
Fluvoxamine—Fatigue—Pamidronate—osteoporosis	0.000101	0.000351	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Risedronate—osteoporosis	0.000101	0.00035	CcSEcCtD
Fluvoxamine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000101	0.000349	CcSEcCtD
Fluvoxamine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000101	0.000349	CcSEcCtD
Fluvoxamine—Pain—Pamidronate—osteoporosis	0.0001	0.000348	CcSEcCtD
Fluvoxamine—Constipation—Pamidronate—osteoporosis	0.0001	0.000348	CcSEcCtD
Fluvoxamine—Diarrhoea—Calcitriol—osteoporosis	0.0001	0.000348	CcSEcCtD
Fluvoxamine—Hypotension—Zoledronate—osteoporosis	0.0001	0.000347	CcSEcCtD
Fluvoxamine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.0001	0.000347	CcSEcCtD
Fluvoxamine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.0001	0.000347	CcSEcCtD
Fluvoxamine—Dizziness—Raloxifene—osteoporosis	0.0001	0.000347	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	9.99e-05	0.000346	CcSEcCtD
Fluvoxamine—Flatulence—Estradiol—osteoporosis	9.99e-05	0.000346	CcSEcCtD
Fluvoxamine—Tension—Estradiol—osteoporosis	9.95e-05	0.000344	CcSEcCtD
Fluvoxamine—Vomiting—Estropipate—osteoporosis	9.94e-05	0.000344	CcSEcCtD
Fluvoxamine—Dysgeusia—Estradiol—osteoporosis	9.92e-05	0.000344	CcSEcCtD
Fluvoxamine—Dizziness—Ibandronate—osteoporosis	9.92e-05	0.000343	CcSEcCtD
Fluvoxamine—Rash—Estropipate—osteoporosis	9.86e-05	0.000341	CcSEcCtD
Fluvoxamine—Dermatitis—Estropipate—osteoporosis	9.85e-05	0.000341	CcSEcCtD
Fluvoxamine—Anorexia—Conjugated Estrogens—osteoporosis	9.85e-05	0.000341	CcSEcCtD
Fluvoxamine—Nervousness—Estradiol—osteoporosis	9.84e-05	0.000341	CcSEcCtD
Fluvoxamine—Urticaria—Risedronate—osteoporosis	9.82e-05	0.00034	CcSEcCtD
Fluvoxamine—Back pain—Estradiol—osteoporosis	9.8e-05	0.000339	CcSEcCtD
Fluvoxamine—Headache—Estropipate—osteoporosis	9.8e-05	0.000339	CcSEcCtD
Fluvoxamine—Vomiting—Alendronate—osteoporosis	9.79e-05	0.000339	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Zoledronate—osteoporosis	9.78e-05	0.000339	CcSEcCtD
Fluvoxamine—Abdominal pain—Risedronate—osteoporosis	9.77e-05	0.000338	CcSEcCtD
Fluvoxamine—Body temperature increased—Risedronate—osteoporosis	9.77e-05	0.000338	CcSEcCtD
Fluvoxamine—Muscle spasms—Estradiol—osteoporosis	9.74e-05	0.000337	CcSEcCtD
Fluvoxamine—Rash—Alendronate—osteoporosis	9.71e-05	0.000336	CcSEcCtD
Fluvoxamine—Insomnia—Zoledronate—osteoporosis	9.71e-05	0.000336	CcSEcCtD
Fluvoxamine—Dermatitis—Alendronate—osteoporosis	9.7e-05	0.000336	CcSEcCtD
Fluvoxamine—Feeling abnormal—Pamidronate—osteoporosis	9.68e-05	0.000335	CcSEcCtD
Fluvoxamine—Hypotension—Conjugated Estrogens—osteoporosis	9.66e-05	0.000334	CcSEcCtD
Fluvoxamine—Headache—Alendronate—osteoporosis	9.65e-05	0.000334	CcSEcCtD
Fluvoxamine—Paraesthesia—Zoledronate—osteoporosis	9.64e-05	0.000334	CcSEcCtD
Fluvoxamine—Vomiting—Raloxifene—osteoporosis	9.63e-05	0.000334	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Pamidronate—osteoporosis	9.61e-05	0.000333	CcSEcCtD
Fluvoxamine—Dyspnoea—Zoledronate—osteoporosis	9.57e-05	0.000331	CcSEcCtD
Fluvoxamine—Rash—Raloxifene—osteoporosis	9.55e-05	0.000331	CcSEcCtD
Fluvoxamine—Dermatitis—Raloxifene—osteoporosis	9.54e-05	0.00033	CcSEcCtD
Fluvoxamine—Somnolence—Zoledronate—osteoporosis	9.54e-05	0.00033	CcSEcCtD
Fluvoxamine—Vomiting—Ibandronate—osteoporosis	9.54e-05	0.00033	CcSEcCtD
Fluvoxamine—Tremor—Estradiol—osteoporosis	9.5e-05	0.000329	CcSEcCtD
Fluvoxamine—Headache—Raloxifene—osteoporosis	9.49e-05	0.000329	CcSEcCtD
Fluvoxamine—Rash—Ibandronate—osteoporosis	9.46e-05	0.000327	CcSEcCtD
Fluvoxamine—Dermatitis—Ibandronate—osteoporosis	9.45e-05	0.000327	CcSEcCtD
Fluvoxamine—Dyspepsia—Zoledronate—osteoporosis	9.45e-05	0.000327	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	9.42e-05	0.000326	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Estradiol—osteoporosis	9.4e-05	0.000326	CcSEcCtD
Fluvoxamine—Headache—Ibandronate—osteoporosis	9.4e-05	0.000325	CcSEcCtD
Fluvoxamine—Insomnia—Conjugated Estrogens—osteoporosis	9.35e-05	0.000324	CcSEcCtD
Fluvoxamine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	9.34e-05	0.000323	CcSEcCtD
Fluvoxamine—Vomiting—Calcitriol—osteoporosis	9.34e-05	0.000323	CcSEcCtD
Fluvoxamine—Decreased appetite—Zoledronate—osteoporosis	9.33e-05	0.000323	CcSEcCtD
Fluvoxamine—Agitation—Estradiol—osteoporosis	9.31e-05	0.000323	CcSEcCtD
Fluvoxamine—Nausea—Estropipate—osteoporosis	9.29e-05	0.000322	CcSEcCtD
Fluvoxamine—Body temperature increased—Pamidronate—osteoporosis	9.29e-05	0.000322	CcSEcCtD
Fluvoxamine—Abdominal pain—Pamidronate—osteoporosis	9.29e-05	0.000322	CcSEcCtD
Fluvoxamine—Paraesthesia—Conjugated Estrogens—osteoporosis	9.28e-05	0.000321	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Zoledronate—osteoporosis	9.27e-05	0.000321	CcSEcCtD
Fluvoxamine—Angioedema—Estradiol—osteoporosis	9.26e-05	0.000321	CcSEcCtD
Fluvoxamine—Rash—Calcitriol—osteoporosis	9.26e-05	0.000321	CcSEcCtD
Fluvoxamine—Fatigue—Zoledronate—osteoporosis	9.25e-05	0.00032	CcSEcCtD
Fluvoxamine—Dermatitis—Calcitriol—osteoporosis	9.25e-05	0.00032	CcSEcCtD
Fluvoxamine—Dyspnoea—Conjugated Estrogens—osteoporosis	9.21e-05	0.000319	CcSEcCtD
Fluvoxamine—Headache—Calcitriol—osteoporosis	9.2e-05	0.000319	CcSEcCtD
Fluvoxamine—Somnolence—Conjugated Estrogens—osteoporosis	9.19e-05	0.000318	CcSEcCtD
Fluvoxamine—Constipation—Zoledronate—osteoporosis	9.18e-05	0.000318	CcSEcCtD
Fluvoxamine—Pain—Zoledronate—osteoporosis	9.18e-05	0.000318	CcSEcCtD
Fluvoxamine—Nausea—Alendronate—osteoporosis	9.15e-05	0.000317	CcSEcCtD
Fluvoxamine—Malaise—Estradiol—osteoporosis	9.14e-05	0.000316	CcSEcCtD
Fluvoxamine—Hypersensitivity—Risedronate—osteoporosis	9.11e-05	0.000315	CcSEcCtD
Fluvoxamine—Vertigo—Estradiol—osteoporosis	9.11e-05	0.000315	CcSEcCtD
Fluvoxamine—Dyspepsia—Conjugated Estrogens—osteoporosis	9.1e-05	0.000315	CcSEcCtD
Fluvoxamine—Asthenia—Ethinyl Estradiol—osteoporosis	9.1e-05	0.000315	CcSEcCtD
Fluvoxamine—Syncope—Estradiol—osteoporosis	9.09e-05	0.000315	CcSEcCtD
Fluvoxamine—Nausea—Raloxifene—osteoporosis	9e-05	0.000312	CcSEcCtD
Fluvoxamine—Decreased appetite—Conjugated Estrogens—osteoporosis	8.98e-05	0.000311	CcSEcCtD
Fluvoxamine—Pruritus—Ethinyl Estradiol—osteoporosis	8.97e-05	0.000311	CcSEcCtD
Fluvoxamine—Palpitations—Estradiol—osteoporosis	8.96e-05	0.00031	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	8.92e-05	0.000309	CcSEcCtD
Fluvoxamine—Fatigue—Conjugated Estrogens—osteoporosis	8.91e-05	0.000309	CcSEcCtD
Fluvoxamine—Nausea—Ibandronate—osteoporosis	8.91e-05	0.000308	CcSEcCtD
Fluvoxamine—Loss of consciousness—Estradiol—osteoporosis	8.91e-05	0.000308	CcSEcCtD
Fluvoxamine—Asthenia—Risedronate—osteoporosis	8.87e-05	0.000307	CcSEcCtD
Fluvoxamine—Feeling abnormal—Zoledronate—osteoporosis	8.84e-05	0.000306	CcSEcCtD
Fluvoxamine—Cough—Estradiol—osteoporosis	8.84e-05	0.000306	CcSEcCtD
Fluvoxamine—Pain—Conjugated Estrogens—osteoporosis	8.84e-05	0.000306	CcSEcCtD
Fluvoxamine—Constipation—Conjugated Estrogens—osteoporosis	8.84e-05	0.000306	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Zoledronate—osteoporosis	8.78e-05	0.000304	CcSEcCtD
Fluvoxamine—Hypertension—Estradiol—osteoporosis	8.75e-05	0.000303	CcSEcCtD
Fluvoxamine—Pruritus—Risedronate—osteoporosis	8.75e-05	0.000303	CcSEcCtD
Fluvoxamine—Nausea—Calcitriol—osteoporosis	8.72e-05	0.000302	CcSEcCtD
Fluvoxamine—Diarrhoea—Ethinyl Estradiol—osteoporosis	8.67e-05	0.0003	CcSEcCtD
Fluvoxamine—Hypersensitivity—Pamidronate—osteoporosis	8.66e-05	0.0003	CcSEcCtD
Fluvoxamine—Chest pain—Estradiol—osteoporosis	8.63e-05	0.000299	CcSEcCtD
Fluvoxamine—Myalgia—Estradiol—osteoporosis	8.63e-05	0.000299	CcSEcCtD
Fluvoxamine—Arthralgia—Estradiol—osteoporosis	8.63e-05	0.000299	CcSEcCtD
Fluvoxamine—Anxiety—Estradiol—osteoporosis	8.6e-05	0.000298	CcSEcCtD
Fluvoxamine—Urticaria—Zoledronate—osteoporosis	8.53e-05	0.000295	CcSEcCtD
Fluvoxamine—Discomfort—Estradiol—osteoporosis	8.52e-05	0.000295	CcSEcCtD
Fluvoxamine—Abdominal pain—Zoledronate—osteoporosis	8.48e-05	0.000294	CcSEcCtD
Fluvoxamine—Body temperature increased—Zoledronate—osteoporosis	8.48e-05	0.000294	CcSEcCtD
Fluvoxamine—Diarrhoea—Risedronate—osteoporosis	8.46e-05	0.000293	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	8.45e-05	0.000293	CcSEcCtD
Fluvoxamine—Dry mouth—Estradiol—osteoporosis	8.44e-05	0.000292	CcSEcCtD
Fluvoxamine—Asthenia—Pamidronate—osteoporosis	8.43e-05	0.000292	CcSEcCtD
Fluvoxamine—Dizziness—Ethinyl Estradiol—osteoporosis	8.38e-05	0.00029	CcSEcCtD
Fluvoxamine—Confusional state—Estradiol—osteoporosis	8.34e-05	0.000289	CcSEcCtD
Fluvoxamine—Pruritus—Pamidronate—osteoporosis	8.31e-05	0.000288	CcSEcCtD
Fluvoxamine—Oedema—Estradiol—osteoporosis	8.27e-05	0.000286	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Estradiol—osteoporosis	8.27e-05	0.000286	CcSEcCtD
Fluvoxamine—Infection—Estradiol—osteoporosis	8.22e-05	0.000285	CcSEcCtD
Fluvoxamine—Urticaria—Conjugated Estrogens—osteoporosis	8.21e-05	0.000284	CcSEcCtD
Fluvoxamine—Dizziness—Risedronate—osteoporosis	8.17e-05	0.000283	CcSEcCtD
Fluvoxamine—Abdominal pain—Conjugated Estrogens—osteoporosis	8.17e-05	0.000283	CcSEcCtD
Fluvoxamine—Body temperature increased—Conjugated Estrogens—osteoporosis	8.17e-05	0.000283	CcSEcCtD
Fluvoxamine—Shock—Estradiol—osteoporosis	8.14e-05	0.000282	CcSEcCtD
Fluvoxamine—Nervous system disorder—Estradiol—osteoporosis	8.11e-05	0.000281	CcSEcCtD
Fluvoxamine—Tachycardia—Estradiol—osteoporosis	8.07e-05	0.00028	CcSEcCtD
Fluvoxamine—Vomiting—Ethinyl Estradiol—osteoporosis	8.06e-05	0.000279	CcSEcCtD
Fluvoxamine—Diarrhoea—Pamidronate—osteoporosis	8.04e-05	0.000278	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Estradiol—osteoporosis	8e-05	0.000277	CcSEcCtD
Fluvoxamine—Rash—Ethinyl Estradiol—osteoporosis	7.99e-05	0.000277	CcSEcCtD
Fluvoxamine—Dermatitis—Ethinyl Estradiol—osteoporosis	7.99e-05	0.000277	CcSEcCtD
Fluvoxamine—Headache—Ethinyl Estradiol—osteoporosis	7.94e-05	0.000275	CcSEcCtD
Fluvoxamine—Hypersensitivity—Zoledronate—osteoporosis	7.91e-05	0.000274	CcSEcCtD
Fluvoxamine—Vomiting—Risedronate—osteoporosis	7.86e-05	0.000272	CcSEcCtD
Fluvoxamine—Rash—Risedronate—osteoporosis	7.79e-05	0.00027	CcSEcCtD
Fluvoxamine—Dermatitis—Risedronate—osteoporosis	7.79e-05	0.00027	CcSEcCtD
Fluvoxamine—Dizziness—Pamidronate—osteoporosis	7.77e-05	0.000269	CcSEcCtD
Fluvoxamine—Headache—Risedronate—osteoporosis	7.74e-05	0.000268	CcSEcCtD
Fluvoxamine—Asthenia—Zoledronate—osteoporosis	7.7e-05	0.000267	CcSEcCtD
Fluvoxamine—Hypersensitivity—Conjugated Estrogens—osteoporosis	7.61e-05	0.000264	CcSEcCtD
Fluvoxamine—Pruritus—Zoledronate—osteoporosis	7.59e-05	0.000263	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Estradiol—osteoporosis	7.54e-05	0.000261	CcSEcCtD
Fluvoxamine—Nausea—Ethinyl Estradiol—osteoporosis	7.53e-05	0.000261	CcSEcCtD
Fluvoxamine—Insomnia—Estradiol—osteoporosis	7.48e-05	0.000259	CcSEcCtD
Fluvoxamine—Vomiting—Pamidronate—osteoporosis	7.47e-05	0.000259	CcSEcCtD
Fluvoxamine—Paraesthesia—Estradiol—osteoporosis	7.43e-05	0.000257	CcSEcCtD
Fluvoxamine—Asthenia—Conjugated Estrogens—osteoporosis	7.41e-05	0.000257	CcSEcCtD
Fluvoxamine—Rash—Pamidronate—osteoporosis	7.41e-05	0.000257	CcSEcCtD
Fluvoxamine—Dermatitis—Pamidronate—osteoporosis	7.4e-05	0.000256	CcSEcCtD
Fluvoxamine—Dyspnoea—Estradiol—osteoporosis	7.37e-05	0.000255	CcSEcCtD
Fluvoxamine—Headache—Pamidronate—osteoporosis	7.36e-05	0.000255	CcSEcCtD
Fluvoxamine—Somnolence—Estradiol—osteoporosis	7.35e-05	0.000255	CcSEcCtD
Fluvoxamine—Diarrhoea—Zoledronate—osteoporosis	7.34e-05	0.000254	CcSEcCtD
Fluvoxamine—Nausea—Risedronate—osteoporosis	7.34e-05	0.000254	CcSEcCtD
Fluvoxamine—Pruritus—Conjugated Estrogens—osteoporosis	7.31e-05	0.000253	CcSEcCtD
Fluvoxamine—Dyspepsia—Estradiol—osteoporosis	7.28e-05	0.000252	CcSEcCtD
Fluvoxamine—Decreased appetite—Estradiol—osteoporosis	7.19e-05	0.000249	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Estradiol—osteoporosis	7.14e-05	0.000247	CcSEcCtD
Fluvoxamine—Fatigue—Estradiol—osteoporosis	7.13e-05	0.000247	CcSEcCtD
Fluvoxamine—Dizziness—Zoledronate—osteoporosis	7.1e-05	0.000246	CcSEcCtD
Fluvoxamine—Constipation—Estradiol—osteoporosis	7.07e-05	0.000245	CcSEcCtD
Fluvoxamine—Pain—Estradiol—osteoporosis	7.07e-05	0.000245	CcSEcCtD
Fluvoxamine—Diarrhoea—Conjugated Estrogens—osteoporosis	7.07e-05	0.000245	CcSEcCtD
Fluvoxamine—Nausea—Pamidronate—osteoporosis	6.98e-05	0.000242	CcSEcCtD
Fluvoxamine—Dizziness—Conjugated Estrogens—osteoporosis	6.83e-05	0.000237	CcSEcCtD
Fluvoxamine—Vomiting—Zoledronate—osteoporosis	6.82e-05	0.000236	CcSEcCtD
Fluvoxamine—Feeling abnormal—Estradiol—osteoporosis	6.82e-05	0.000236	CcSEcCtD
Fluvoxamine—Rash—Zoledronate—osteoporosis	6.77e-05	0.000234	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Estradiol—osteoporosis	6.76e-05	0.000234	CcSEcCtD
Fluvoxamine—Dermatitis—Zoledronate—osteoporosis	6.76e-05	0.000234	CcSEcCtD
Fluvoxamine—Headache—Zoledronate—osteoporosis	6.72e-05	0.000233	CcSEcCtD
Fluvoxamine—Vomiting—Conjugated Estrogens—osteoporosis	6.57e-05	0.000228	CcSEcCtD
Fluvoxamine—Urticaria—Estradiol—osteoporosis	6.57e-05	0.000228	CcSEcCtD
Fluvoxamine—Body temperature increased—Estradiol—osteoporosis	6.54e-05	0.000226	CcSEcCtD
Fluvoxamine—Abdominal pain—Estradiol—osteoporosis	6.54e-05	0.000226	CcSEcCtD
Fluvoxamine—Rash—Conjugated Estrogens—osteoporosis	6.52e-05	0.000226	CcSEcCtD
Fluvoxamine—Dermatitis—Conjugated Estrogens—osteoporosis	6.51e-05	0.000225	CcSEcCtD
Fluvoxamine—Headache—Conjugated Estrogens—osteoporosis	6.47e-05	0.000224	CcSEcCtD
Fluvoxamine—Nausea—Zoledronate—osteoporosis	6.38e-05	0.000221	CcSEcCtD
Fluvoxamine—Nausea—Conjugated Estrogens—osteoporosis	6.14e-05	0.000213	CcSEcCtD
Fluvoxamine—Hypersensitivity—Estradiol—osteoporosis	6.09e-05	0.000211	CcSEcCtD
Fluvoxamine—Asthenia—Estradiol—osteoporosis	5.93e-05	0.000205	CcSEcCtD
Fluvoxamine—Pruritus—Estradiol—osteoporosis	5.85e-05	0.000203	CcSEcCtD
Fluvoxamine—Diarrhoea—Estradiol—osteoporosis	5.66e-05	0.000196	CcSEcCtD
Fluvoxamine—Dizziness—Estradiol—osteoporosis	5.47e-05	0.000189	CcSEcCtD
Fluvoxamine—Vomiting—Estradiol—osteoporosis	5.26e-05	0.000182	CcSEcCtD
Fluvoxamine—Rash—Estradiol—osteoporosis	5.22e-05	0.000181	CcSEcCtD
Fluvoxamine—Dermatitis—Estradiol—osteoporosis	5.21e-05	0.00018	CcSEcCtD
Fluvoxamine—Headache—Estradiol—osteoporosis	5.18e-05	0.000179	CcSEcCtD
Fluvoxamine—Nausea—Estradiol—osteoporosis	4.91e-05	0.00017	CcSEcCtD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.18e-05	0.000738	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ACP5—osteoporosis	2.18e-05	0.000738	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PKM—osteoporosis	2.13e-05	0.000721	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—FDPS—osteoporosis	2.13e-05	0.000721	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CA2—osteoporosis	2.13e-05	0.00072	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—OXCT1—osteoporosis	2.13e-05	0.00072	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—POMC—osteoporosis	2.13e-05	0.00072	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—POMC—osteoporosis	2.11e-05	0.000714	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CA2—osteoporosis	2.09e-05	0.000706	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—OXCT1—osteoporosis	2.09e-05	0.000706	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CA2—osteoporosis	2.08e-05	0.000704	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—OXCT1—osteoporosis	2.08e-05	0.000704	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MGLL—osteoporosis	2.08e-05	0.000702	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GPD2—osteoporosis	2.07e-05	0.0007	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PGLS—osteoporosis	2.07e-05	0.0007	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MGLL—osteoporosis	2.03e-05	0.000688	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—TPI1—osteoporosis	2.03e-05	0.000686	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MGLL—osteoporosis	2.03e-05	0.000686	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PGLS—osteoporosis	2.02e-05	0.000683	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GPD2—osteoporosis	2.02e-05	0.000683	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PKM—osteoporosis	2.01e-05	0.000679	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—FDPS—osteoporosis	2.01e-05	0.000679	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	2e-05	0.000676	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—FDPS—osteoporosis	1.99e-05	0.000673	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PKM—osteoporosis	1.99e-05	0.000673	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CA2—osteoporosis	1.97e-05	0.000665	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—OXCT1—osteoporosis	1.97e-05	0.000665	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MGLL—osteoporosis	1.92e-05	0.000648	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—P4HB—osteoporosis	1.91e-05	0.000645	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PGLS—osteoporosis	1.9e-05	0.000644	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GPD2—osteoporosis	1.9e-05	0.000644	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ATIC—osteoporosis	1.89e-05	0.00064	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PNP—osteoporosis	1.89e-05	0.00064	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GPD2—osteoporosis	1.89e-05	0.000638	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PGLS—osteoporosis	1.89e-05	0.000638	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GAPDH—osteoporosis	1.87e-05	0.000633	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.87e-05	0.000631	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PNP—osteoporosis	1.85e-05	0.000625	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ATIC—osteoporosis	1.85e-05	0.000625	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—RAP1A—osteoporosis	1.83e-05	0.000617	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.81e-05	0.000611	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—POMC—osteoporosis	1.8e-05	0.00061	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—IDH2—osteoporosis	1.77e-05	0.000597	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ATIC—osteoporosis	1.74e-05	0.000589	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PNP—osteoporosis	1.74e-05	0.000589	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—IDH2—osteoporosis	1.73e-05	0.000585	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PNP—osteoporosis	1.73e-05	0.000584	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ATIC—osteoporosis	1.73e-05	0.000584	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—IDH2—osteoporosis	1.73e-05	0.000584	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—FDPS—osteoporosis	1.7e-05	0.000575	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PKM—osteoporosis	1.7e-05	0.000575	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP27A1—osteoporosis	1.66e-05	0.000561	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—IDH2—osteoporosis	1.63e-05	0.000551	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYP27A1—osteoporosis	1.63e-05	0.00055	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP27A1—osteoporosis	1.62e-05	0.000549	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ACP5—osteoporosis	1.62e-05	0.000546	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GPD2—osteoporosis	1.61e-05	0.000546	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PGLS—osteoporosis	1.61e-05	0.000546	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CA2—osteoporosis	1.61e-05	0.000544	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—OXCT1—osteoporosis	1.61e-05	0.000544	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ACP5—osteoporosis	1.58e-05	0.000535	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ACP5—osteoporosis	1.58e-05	0.000534	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CA2—osteoporosis	1.57e-05	0.000531	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—OXCT1—osteoporosis	1.57e-05	0.000531	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MGLL—osteoporosis	1.57e-05	0.000531	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP27A1—osteoporosis	1.53e-05	0.000518	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MGLL—osteoporosis	1.53e-05	0.000518	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—TPI1—osteoporosis	1.5e-05	0.000508	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ACP5—osteoporosis	1.49e-05	0.000504	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—OXCT1—osteoporosis	1.48e-05	0.000501	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CA2—osteoporosis	1.48e-05	0.000501	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.48e-05	0.0005	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PNP—osteoporosis	1.48e-05	0.000499	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ATIC—osteoporosis	1.48e-05	0.000499	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ENO1—osteoporosis	1.48e-05	0.000499	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.47e-05	0.000498	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—TPI1—osteoporosis	1.47e-05	0.000497	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CA2—osteoporosis	1.47e-05	0.000496	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—OXCT1—osteoporosis	1.47e-05	0.000496	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—TPI1—osteoporosis	1.47e-05	0.000496	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PSMA5—osteoporosis	1.45e-05	0.000491	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PSMA2—osteoporosis	1.45e-05	0.000491	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MGLL—osteoporosis	1.44e-05	0.000488	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MGLL—osteoporosis	1.43e-05	0.000484	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—P4HB—osteoporosis	1.41e-05	0.000477	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—POMC—osteoporosis	1.39e-05	0.000471	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—TPI1—osteoporosis	1.39e-05	0.000469	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GAPDH—osteoporosis	1.39e-05	0.000468	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—P4HB—osteoporosis	1.38e-05	0.000467	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—P4HB—osteoporosis	1.38e-05	0.000467	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GAPDH—osteoporosis	1.36e-05	0.000459	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GAPDH—osteoporosis	1.35e-05	0.000458	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—RAP1A—osteoporosis	1.35e-05	0.000456	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.35e-05	0.000456	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—IDH2—osteoporosis	1.33e-05	0.000451	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—RAP1A—osteoporosis	1.32e-05	0.000447	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—RAP1A—osteoporosis	1.32e-05	0.000446	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PKM—osteoporosis	1.31e-05	0.000444	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—FDPS—osteoporosis	1.31e-05	0.000444	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—P4HB—osteoporosis	1.3e-05	0.000441	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—IDH2—osteoporosis	1.3e-05	0.00044	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GAPDH—osteoporosis	1.28e-05	0.000433	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—OXCT1—osteoporosis	1.26e-05	0.000424	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CA2—osteoporosis	1.26e-05	0.000424	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.25e-05	0.000424	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—RAP1A—osteoporosis	1.25e-05	0.000421	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GPD2—osteoporosis	1.25e-05	0.000421	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PGLS—osteoporosis	1.25e-05	0.000421	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—IDH2—osteoporosis	1.23e-05	0.000415	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP27A1—osteoporosis	1.22e-05	0.000414	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MGLL—osteoporosis	1.22e-05	0.000413	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ACP5—osteoporosis	1.22e-05	0.000413	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—IDH2—osteoporosis	1.22e-05	0.000411	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.21e-05	0.000407	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.2e-05	0.000406	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.2e-05	0.000405	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ACP5—osteoporosis	1.19e-05	0.000403	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CYP19A1—osteoporosis	1.18e-05	0.000399	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.15e-05	0.00039	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.15e-05	0.00039	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.14e-05	0.000387	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ATIC—osteoporosis	1.14e-05	0.000385	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PNP—osteoporosis	1.14e-05	0.000385	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—TPI1—osteoporosis	1.13e-05	0.000384	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ACP5—osteoporosis	1.12e-05	0.00038	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.12e-05	0.000379	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.12e-05	0.000378	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ACP5—osteoporosis	1.11e-05	0.000376	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—TPI1—osteoporosis	1.11e-05	0.000374	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.1e-05	0.000371	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ENO1—osteoporosis	1.09e-05	0.000369	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.09e-05	0.000367	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PSMA2—osteoporosis	1.08e-05	0.000363	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PSMA5—osteoporosis	1.08e-05	0.000363	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ENO1—osteoporosis	1.07e-05	0.000361	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—P4HB—osteoporosis	1.07e-05	0.000361	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ENO1—osteoporosis	1.07e-05	0.000361	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PSMA5—osteoporosis	1.05e-05	0.000356	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PSMA2—osteoporosis	1.05e-05	0.000356	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PSMA5—osteoporosis	1.05e-05	0.000355	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PSMA2—osteoporosis	1.05e-05	0.000355	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GAPDH—osteoporosis	1.05e-05	0.000354	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—TPI1—osteoporosis	1.04e-05	0.000353	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—P4HB—osteoporosis	1.04e-05	0.000352	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—IDH2—osteoporosis	1.04e-05	0.000352	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—TPI1—osteoporosis	1.03e-05	0.00035	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GAPDH—osteoporosis	1.02e-05	0.000346	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—RAP1A—osteoporosis	1.02e-05	0.000345	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ENO1—osteoporosis	1.01e-05	0.000341	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—RAP1A—osteoporosis	9.96e-06	0.000337	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PSMA2—osteoporosis	9.93e-06	0.000336	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PSMA5—osteoporosis	9.93e-06	0.000336	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—P4HB—osteoporosis	9.81e-06	0.000332	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP27A1—osteoporosis	9.78e-06	0.000331	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—P4HB—osteoporosis	9.73e-06	0.000329	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—OXCT1—osteoporosis	9.69e-06	0.000327	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CA2—osteoporosis	9.69e-06	0.000327	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ADCY5—osteoporosis	9.64e-06	0.000326	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GAPDH—osteoporosis	9.63e-06	0.000326	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GPX1—osteoporosis	9.6e-06	0.000325	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GAPDH—osteoporosis	9.55e-06	0.000323	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ACP5—osteoporosis	9.51e-06	0.000322	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MGLL—osteoporosis	9.44e-06	0.000319	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	9.39e-06	0.000317	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—RAP1A—osteoporosis	9.38e-06	0.000317	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—RAP1A—osteoporosis	9.3e-06	0.000314	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.9e-06	0.000301	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—MTHFR—osteoporosis	8.86e-06	0.0003	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—TPI1—osteoporosis	8.84e-06	0.000299	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP19A1—osteoporosis	8.72e-06	0.000295	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYP19A1—osteoporosis	8.54e-06	0.000289	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP19A1—osteoporosis	8.53e-06	0.000288	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—P4HB—osteoporosis	8.31e-06	0.000281	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ENO1—osteoporosis	8.25e-06	0.000279	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GAPDH—osteoporosis	8.16e-06	0.000276	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PSMA5—osteoporosis	8.12e-06	0.000275	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PSMA2—osteoporosis	8.12e-06	0.000275	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.11e-06	0.000274	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP19A1—osteoporosis	8.06e-06	0.000272	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ENO1—osteoporosis	8.05e-06	0.000272	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—IDH2—osteoporosis	8.03e-06	0.000271	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—RAP1A—osteoporosis	7.95e-06	0.000269	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PSMA2—osteoporosis	7.93e-06	0.000268	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PSMA5—osteoporosis	7.93e-06	0.000268	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ENO1—osteoporosis	7.58e-06	0.000256	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP27A1—osteoporosis	7.55e-06	0.000255	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ENO1—osteoporosis	7.52e-06	0.000254	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PSMA5—osteoporosis	7.47e-06	0.000253	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PSMA2—osteoporosis	7.47e-06	0.000253	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PSMA2—osteoporosis	7.41e-06	0.00025	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PSMA5—osteoporosis	7.41e-06	0.00025	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ACP5—osteoporosis	7.34e-06	0.000248	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ADCY5—osteoporosis	7.13e-06	0.000241	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GPX1—osteoporosis	7.1e-06	0.00024	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—POMC—osteoporosis	7.09e-06	0.00024	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ADCY5—osteoporosis	6.98e-06	0.000236	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ADCY5—osteoporosis	6.97e-06	0.000235	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GPX1—osteoporosis	6.96e-06	0.000235	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GPX1—osteoporosis	6.94e-06	0.000235	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.93e-06	0.000234	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—TPI1—osteoporosis	6.82e-06	0.000231	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP19A1—osteoporosis	6.59e-06	0.000223	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ADCY5—osteoporosis	6.58e-06	0.000222	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GPX1—osteoporosis	6.56e-06	0.000222	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MTHFR—osteoporosis	6.56e-06	0.000222	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP19A1—osteoporosis	6.43e-06	0.000217	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ENO1—osteoporosis	6.42e-06	0.000217	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MTHFR—osteoporosis	6.42e-06	0.000217	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—P4HB—osteoporosis	6.42e-06	0.000217	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MTHFR—osteoporosis	6.41e-06	0.000217	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PSMA2—osteoporosis	6.33e-06	0.000214	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PSMA5—osteoporosis	6.33e-06	0.000214	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GAPDH—osteoporosis	6.3e-06	0.000213	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—RAP1A—osteoporosis	6.13e-06	0.000207	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP19A1—osteoporosis	6.06e-06	0.000205	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MTHFR—osteoporosis	6.05e-06	0.000205	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP19A1—osteoporosis	6.01e-06	0.000203	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ADCY5—osteoporosis	5.39e-06	0.000182	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GPX1—osteoporosis	5.37e-06	0.000181	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ADCY5—osteoporosis	5.26e-06	0.000178	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—POMC—osteoporosis	5.24e-06	0.000177	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GPX1—osteoporosis	5.24e-06	0.000177	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP19A1—osteoporosis	5.14e-06	0.000174	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—POMC—osteoporosis	5.13e-06	0.000174	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—POMC—osteoporosis	5.12e-06	0.000173	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ENO1—osteoporosis	4.96e-06	0.000168	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ADCY5—osteoporosis	4.95e-06	0.000167	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MTHFR—osteoporosis	4.95e-06	0.000167	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GPX1—osteoporosis	4.94e-06	0.000167	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ADCY5—osteoporosis	4.91e-06	0.000166	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GPX1—osteoporosis	4.89e-06	0.000165	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PSMA2—osteoporosis	4.89e-06	0.000165	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PSMA5—osteoporosis	4.89e-06	0.000165	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—POMC—osteoporosis	4.84e-06	0.000164	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MTHFR—osteoporosis	4.83e-06	0.000163	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MTHFR—osteoporosis	4.56e-06	0.000154	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MTHFR—osteoporosis	4.52e-06	0.000153	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ADCY5—osteoporosis	4.2e-06	0.000142	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GPX1—osteoporosis	4.18e-06	0.000141	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.96e-06	0.000134	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—POMC—osteoporosis	3.96e-06	0.000134	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—POMC—osteoporosis	3.87e-06	0.000131	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MTHFR—osteoporosis	3.86e-06	0.00013	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—POMC—osteoporosis	3.64e-06	0.000123	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—POMC—osteoporosis	3.61e-06	0.000122	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ADCY5—osteoporosis	3.24e-06	0.000109	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GPX1—osteoporosis	3.23e-06	0.000109	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—POMC—osteoporosis	3.09e-06	0.000104	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MTHFR—osteoporosis	2.98e-06	0.000101	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—POMC—osteoporosis	2.38e-06	8.05e-05	CbGpPWpGaD
